Grant: CIHR Clinician Scientist - Phase 1
University of Toronto
$57,500.00
Identification and Characterization of Human Liver Cancer Stem Cells
EF 2011-12
Résumé
Primary liver cancer is the fifth most common cancer worldwide and the most rapidly increasing cause of death from cancer in North America. Patients with early stages of disease can be effectively treated with surgery, but treatments for patients with more advanced disease are ineffective and the prognosis is poor. The ways in which liver cancers develop and progress are not well understood; a better understanding should lead to opportunities for the development of more effective treatments. Recent studies in other types of cancer have shown that only a few cells in a tumor, called cancer stem cells, are responsible for starting the tumor and determining how it grows, spreads, and responds to treatment. The role that such cells may play in liver cancer is not well understood. The goals of this study are to determine whether liver cancers originate from cancer stem cells, and if so, to determine unique characteristics of these cells that will allow them to be isolated. To achieve these goals, we will obtain samples of liver cancers from patients having surgery for this condition and grow the human liver cancers in laboratory mice and in flasks. This approach will provide us the most realistic model for studying human liver cancer. We will determine what fraction of the liver cancer cells can actually start new tumors in these models, and we will decipher the unique signatures these cancer stem cells have. The ability to specifically identify the cells responsible for liver cancer development will allow further research to better understand how these cells work and may reveal unique properties of these cells against which new treatments for liver cancer can be developed in order to help the many people who suffer from this common and often lethal disease.
Programme
CIHR Clinician Scientist - Phase 1
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
244955
Name
Ghanekar Anand
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Identification and Characterization of Human Liver Cancer Stem Cells
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$57,500
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Cancer; Cancer Stem Cell; Cellular Biology; Hepatocellular Carcinoma; Liver; Molecular Biology; Primary Cells; Tissue Culture; Tumor Initiation; Xenograft
Abstract
Primary liver cancer is the fifth most common cancer worldwide and the most rapidly increasing cause of death from cancer in North America. Patients with early stages of disease can be effectively treated with surgery, but treatments for patients with more advanced disease are ineffective and the prognosis is poor. The ways in which liver cancers develop and progress are not well understood; a better understanding should lead to opportunities for the development of more effective treatments. Recent studies in other types of cancer have shown that only a few cells in a tumor, called cancer stem cells, are responsible for starting the tumor and determining how it grows, spreads, and responds to treatment. The role that such cells may play in liver cancer is not well understood. The goals of this study are to determine whether liver cancers originate from cancer stem cells, and if so, to determine unique characteristics of these cells that will allow them to be isolated. To achieve these goals, we will obtain samples of liver cancers from patients having surgery for this condition and grow the human liver cancers in laboratory mice and in flasks. This approach will provide us the most realistic model for studying human liver cancer. We will determine what fraction of the liver cancer cells can actually start new tumors in these models, and we will decipher the unique signatures these cancer stem cells have. The ability to specifically identify the cells responsible for liver cancer development will allow further research to better understand how these cells work and may reveal unique properties of these cells against which new treatments for liver cancer can be developed in order to help the many people who suffer from this common and often lethal disease.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ghanekar, Anand
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $57,500~ $0~